Although hepatitis B-containing vaccines are indicated throughout EMRO countries, coverage estimates for 1-year olds in EMRO ranged from 41% in Syria to 99% in Morocco for 2015 [59]. This evidence concerns the gene PPIB and hepatitis A virus infection.